Latest Articles
Karnataka: Woman treated for severe endometriosis, pelvic abscess & sepsis managed; successful surgery at - Times of India
Karnataka: Woman treated for severe endometriosis, pelvic abscess & sepsis managed; successful surgery at Times of India
Published: Aug. 31, 2025, 8:32 a.m.
KMC Hospital Attavar successfully treats rare case of endometriosis with frozen pelvis - Daijiworld
KMC Hospital Attavar successfully treats rare case of endometriosis with frozen pelvis Daijiworld
Published: Aug. 29, 2025, 9:19 a.m.
Hospital accredited as centre of excellence for endometriosis treatment - Lichfield Live
Hospital accredited as centre of excellence for endometriosis treatment Lichfield Live
Published: Aug. 29, 2025, 7:01 a.m.
Endometriosis Treatment Market Size & Growth 2025–2034 - Global Market Insights Inc.
Endometriosis Treatment Market Size & Growth 2025–2034 Global Market Insights Inc.
Published: Aug. 29, 2025, 12:31 a.m.
Genmab shares rise 1.21% premarket after FDA grants Breakthrough Therapy Designation to Rina-S for endometrial cancer treatment. - AInvest
Genmab shares rise 1.21% premarket after FDA grants Breakthrough Therapy Designation to Rina-S for endometrial cancer treatment. AInvest
Published: Aug. 28, 2025, 8:24 a.m.
Innovative Technique for Adolescent Cervical Endometriosis Treatment - BIOENGINEER.ORG
Innovative Technique for Adolescent Cervical Endometriosis Treatment BIOENGINEER.ORG
Published: Aug. 26, 2025, 5:30 p.m.
Innovative Technique for Adolescent Cervical Endometriosis Treatment - bioengineer.org
Innovative Technique for Adolescent Cervical Endometriosis Treatment bioengineer.org
Published: Aug. 26, 2025, 5:30 p.m.
GSK expands cancer treatment options in India with launch of immunotherapy and PARP inhibitor - connectedtoindia.com
GSK expands cancer treatment options in India with launch of immunotherapy and PARP inhibitor connectedtoindia.com
Published: Aug. 26, 2025, 4:39 a.m.
AstraZeneca’s DESTINY-Endometrial01: A New Frontier in Endometrial Cancer Treatment - TipRanks
AstraZeneca’s DESTINY-Endometrial01: A New Frontier in Endometrial Cancer Treatment TipRanks
Published: Aug. 24, 2025, 4:50 p.m.
AstraZeneca’s DESTINY-Endometrial01 Study: A New Horizon in Endometrial Cancer Treatment - TipRanks
AstraZeneca’s DESTINY-Endometrial01 Study: A New Horizon in Endometrial Cancer Treatment TipRanks
Published: Aug. 23, 2025, 6:45 a.m.
Link copied to clipboard!